SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-24-002929
Filing Date
2024-02-06
Accepted
2024-02-06 17:57:39
Documents
1
Period of Report
2024-02-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4077
  Complete submission text file 0001209191-24-002929.txt   5555
Mailing Address C/O SCPHARMACEUTICALS, INC. 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01830
Business Address
Agger Mette Kirstine (Reporting) CIK: 0001722234 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41855 | Film No.: 24601482

Mailing Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010 (212) 547-9879
Lexeo Therapeutics, Inc. (Issuer) CIK: 0001907108 (see all company filings)

IRS No.: 854012572 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)